01 12Gilead Sciences Canada Inc.
01 32682230
02 12761258
03 32794669
04 12815082
05 12840242
06 12852867
07 12856529
08 12877005
01 5LEDIPASVIR | SOFOSBUVIR
02 3SOFOSBUVIR
03 4SOFOSBUVIR | VELPATASVIR | VOXILAPREVIR
01 12TABLET
01 32028-03-26
02 12030-05-12
03 32031-03-31
04 12032-09-14
05 12032-11-16
06 12032-11-27
07 12033-07-02
08 12034-01-30
Patent Expiration Date : 2028-03-26
Date Granted : 2014-04-22
Brand Name : SOVALDI
Patent Number : 2682230
Filing Date : 2008-03-26
Strength per Unit : 400 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-03-26
Date Granted : 2014-04-22
Patent Expiration Date : 2028-03-26
Date Granted : 2014-04-22
Brand Name : HARVONI
Patent Number : 2682230
Filing Date : 2008-03-26
Strength per Unit : 90 mg / 400 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-03-26
Date Granted : 2014-04-22
Patent Expiration Date : 2030-05-12
Date Granted : 2015-08-04
Brand Name : HARVONI
Patent Number : 2761258
Filing Date : 2010-05-12
Strength per Unit : 90 mg / 400 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2030-05-12
Date Granted : 2015-08-04
Patent Expiration Date : 2031-03-31
Date Granted : 2016-10-11
Brand Name : SOVALDI
Patent Number : 2794669
Filing Date : 2011-03-31
Strength per Unit : 400 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-03-31
Date Granted : 2016-10-11
Patent Expiration Date : 2031-03-31
Date Granted : 2016-10-11
Brand Name : HARVONI
Patent Number : 2794669
Filing Date : 2011-03-31
Strength per Unit : 90 mg / 400 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-03-31
Date Granted : 2016-10-11
Patent Expiration Date : 2034-01-30
Date Granted : 2016-12-06
Brand Name : HARVONI
Patent Number : 2852867
Filing Date : 2014-01-30
Strength per Unit : 90 mg / 400 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2034-01-30
Date Granted : 2016-12-06
Patent Expiration Date : 2032-11-27
Date Granted : 2018-03-06
Brand Name : SOVALDI
Patent Number : 2856529
Filing Date : 2012-11-27
Strength per Unit : 400 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2032-11-27
Date Granted : 2018-03-06
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2032-09-14
Date Granted : 2019-03-26
Brand Name : HARVONI
Patent Number : 2840242
Filing Date : 2012-09-14
Strength per Unit : 90 mg / 400 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2032-09-14
Date Granted : 2019-03-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-03-26
Date Granted : 2014-04-22
SOFOSBUVIR, VELPATASVIR, VOXILAPREVIR
Brand Name : VOSEVI
Patent Number : 2682230
Filing Date : 2008-03-26
Strength per Unit : 400 mg / 100 mg / 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-03-26
Date Granted : 2014-04-22
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-03-31
Date Granted : 2016-10-11
SOFOSBUVIR, VELPATASVIR, VOXILAPREVIR
Brand Name : VOSEVI
Patent Number : 2794669
Filing Date : 2011-03-31
Strength per Unit : 400 mg / 100 mg / 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2031-03-31
Date Granted : 2016-10-11
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
